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Abstract: Cardiac hypertrophy (CH), leading to cardiac failure is due to chronic metabolic alterations occurring during cellular stress.
Besides the already known relationship between oxidative stress and CH, there are implications of reductive stress leading to CH.
This study attempted to develop reductive stress-based CH rat model using n-acetyl-L-cysteine (NAC), a glutathione agonist that was
compared with typical isoproterenol (ISO) induced CH model. The main objective was to identify serum metabolites that can serve
as potent predictors for seven routine clinical and diagnostic parameters in CH: 3-hydroxybutyrate (3-HB), lactic acid (LA), urea, and
ECG-CH parameters (QRS complex, R-amplitude, R-R interval, heart rate) that were hypothesized to underlie metabolic remodelling in
this study. CH was assessed using electrocardiography, hypertrophic index and histopathological analysis (H&E stain) in both ventricles
after 2 weeks. Gas chromatography mass spectroscopy analysis (GC-MS) identified unique metabolite finger-prints. Correlation and
pattern analysis revealed strong relationships between specific metabolites and parameters (Pearson’s score > 0.7) of this study. Multiple
regression analysis (MRA) for the strongly related metabolites (independent variables) with each of the seven parameters (dependent
variables) identified significant predictors for the latter namely fructose, valine, butanoic acid in NAC and cholesterol, erythrose,
isoleucine in ISO models, with proline and succinic acid as common for both models. Metabolite set enrichment analysis (MSEA)
of those significant predictors (p < 0.05) mapped butyrate metabolism as highly influential pathway in NAC, with arginine-proline
metabolism and branched chain amino acid (BCAA) degradation as common pathways in both models, thus providing new insights
towards initial metabolic remodeling in the pathogenesis of CH.
Key words: Cardiac hypertrophy, serum predictors, reductive stress, metabolic remodeling, n-acetyl-L-cysteine, isoproterenol

1. Introduction
Cardiac hypertrophy (CH) is the gradual and asymptomatic
enlargement and inflammation of ventricular walls
characterized by accumulation of extracellular matrix
(ECM) proteins. This accumulation was addressed as
cardiac fibrosis (CF) which leads to contractile dysfunction
and heart failure. CH is caused primarily by the metabolic
alterations that are initiated as adaptive mechanisms for
energy production during cellular stress related with
metabolic diseases/syndromes like diabetes, hypertension,
obesity, pregnancy, exposure to drug or radiotherapy, and
vigorous exercises (Gibb and Hill, 2017).
Isoproterenol is a β-adrenergic receptor agonist which
is used to develop CH model based on oxidative stress
and impaired antioxidant systems through downregulated
nuclear erythroid like factor 2 (Nrf2). Therapies that
activate Nrf2, antioxidants, and reduced glutathione have
been reported to ameliorate oxidative stress associated
CH (Erkens et al., 2015). Reductive stress (RS) refers to

the increase in the synthesis of reduced glutathione and
NADH by endogenous mechanisms such as constitutively
active and unregulated Nrf2-antioxidants, hyperglycemia,
and vigorous exercise (Rajasekaran et al., 2005; Yan 2014).
The objectives of this study are to fundamentally
understand the early remodelling events during reduction
(RS) - oxidation (OS) referred as redox stress on the
basis of metabolite shifts by developing in-vivo rat model
of RS using n-acetyl-L-cysteine (NAC) and compared
with the standard oxidative stress-based CH model,
isoproterenol (ISO). The main objective of this study
is the identification of predictors for seven routinely
preferred clinical parameters in CH comorbidities namely
3-hydroxybutyrate (3-HB), lactic acid (LA), urea, and
ECG peaks for CH (QRS complex, R-amplitude, R-R
interval, heart rate) that were hypothesized to underlie
metabolic remodelling in this study with the perspective
of fore-casting CH through redox stress based metabolite
remodelling.
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2. Materials and methods
2.1. Chemicals
All chemicals and reagents used were analytical
grade (Hi Media Pvt Ltd., India). N-trimethylsilyl-Nmethyl trifluoroacetamide (MSTFA), methoxyamine
hydrochloride, n-acetyl-L-cysteine, and isoproterenol
(isoprenaline hydrochloride) were purchased from SigmaAldrich.
2.2. Experimental rats
Male Sprague Dawley rats (5 weeks old; 100 to 110 g
body weight) procured after ethical clearance (CPCSEA/
No.: 399/2018/IAEC) were acclimatized (3 days) under
controlled temperature (29 oC ± 5 oC), humidity (55%
± 5%), and 12 h of light/dark cycles. They were divided
into two groups (n = 5 rats each) and induced cardiac
hypertrophy (CH) in 2 weeks: Group 1 – normal (control -NOR)
Group 2 – n-acetyl L-cysteine (NAC -1g/kg/day, oral)
(Liu et al., 2015)
Group 3 - isoproterenol (ISO -10 mg/kg, i.p) (Doss et
al., 2019)
2.3. Electrocardiography (ECG) analysis of CH
In order to monitor the cardiac functions in vivo after
2 weeks, electrocardiography (ECG) was performed
for 6 min at the conventional bipolar limb lead II using
BITalino ECG Sensor – Open Signals[r]evolution software
in unanesthetized rats. The changes in QRS complex, R
amplitude, R–R interval, and pulse/heart beat rate (HR)
were recorded. These changes were calculated as: [(ECG
parameter value in CH model - in NOR)/(in NOR) x100]
(Konopelski and Ufnal, 2016; Doss and Kuberapandian,
2019).
2.4. Hypertrophy index
The heart size in a rat model was determined by the heart
weight to body weight ratio (Doss and Kuberapandian,
2019).
2.5. Histopathological analysis
The heart tissues were excised and initially preserved in
10% formaldehyde until their left and right ventricles were
processed and stained with haematoxylin and eosin (H&E).
Cellular architecture was examined at 40x magnification
(Zahkouk et al., 2015; Doss et al., 2019)
2.6. Gas chromatography-mass spectroscopy analysis
Serum was isolated from the cardiac blood (punctured
after over-night fasting) as per the modified protocol
(Sowndarya and Doss, 2017). Briefly, serum (100 µL)
was precipitated using acetonitrile (250 µL), evaporated
to dryness (N2 gas), and treated with methoxylamine
hydrochloride (20 mg/mL in pyridine) at 70 °C for 60 min
and MSTFA at 40 °C for 90 min. One µL of the sample was
injected into the inlet port (10:1 split mode) and analysed
using a Shimadzu GC-2010 plus gas chromatography
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instrument coupled to a Shimadzu QP2010 mass
spectrometer (Shimadzu, Japan) with helium (carrier gas)
at flow rate of 1 mL/min with following conditions: initial
temperature (100 °C for 4 min) to 270 °C (5 °C/min);
injection (280 °C); interface (250 °C); ion source (200
°C); solvent delay (9 min). MS was operated in electron
ionisation mode (70 eV; m/z of 35 to 800) followed by the
identification of metabolites based on Nist & Wiley mass
library (ribitol as reference).
2.7. Statistical analysis
Specific and comprehensive analysis using Pearson’s
correlation and pattern analysis along with metabolite set
enrichment analysis (MSEA - SMPDB library) were done
using MetaboAnalyst 4.0 (Chong et al., 2019). Multiple
regression analysis and individual linear regression
prediction models were performed using Statistical
Package for Social Sciences v: 26.0 (SPSS IBM, Armonk,
NY, USA). This software verified data which was expressed
as mean ± standard error by one way analysis of variance
(ANOVA) with significance set at p < 0.05 (Sowndarya
and Doss, 2017; Dhakal, 2019; Doss and Kuberapandian,
2019).
3. Results
3.1. ECG screening for CH in DC
Widened QRS complex with prolonged R-R interval and
impaired HR were observed in both the ISO and NAC
models when compared to normal. The NAC administered
rats displayed shortened R amplitude, unlike the standard
CH model, ISO group that revealed elevated R-amplitude
(Table 1 and Figure S1).
3.2 Hypertrophy index
Morphologically, enlarged ventricles were observed in
both NAC and ISO models when compared to the normal
model (Figure S2). Significant decrease in body weight was
observed in NAC model when compared to the normal
and ISO models. Though, the heart weight was decreased
in NAC which was contrary to the standard ISO model,
the heart weight to body weight ratio was significantly
increased in the NAC model (Table 2).
3.3. Histopathological analysis
When compared to the normal and ISO groups, NAC
administration revealed thickened and distorted
myofibrillar architecture of the left and right ventricles
(Figure S3).
3.4. Gas chromatography-mass spectroscopy analysis
The shifts among 26 metabolites along with
3-hydroxybutyrate, lactic acid, and urea were revealed
in the sera of NAC and ISO when compared to normal.
On comparison with the normal serum, glutamic acid,
2-deoxygalactose, and succinic acid were found at high
levels in ISO and NAC samples with very low levels
of serum cholesterol. Butanoic acid was exclusively
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Table 1. Screening CH characteristics and ventricular function using ECG.
Groups
I - NOR

QRS complex
R amplitude
% change
(ms)
(mV)
19.30 ± 0.52 0.43 ± 0.05

II - NAC 16.70 ± 0.10a
III - ISO

21.00 ± 4.51

b

13.86
9.11

% change
-

0.30 ± 0.08 a* 30.90
0.80 ± 0.07 b* 87.85

R-R interval
(ms)
162.49 ± 2.93

% change
-

180.00 ± 5.98a* 10.73
198.00 ± 2.55 b* 21.85

Heart rate (HR)
% change
(bpm)
369.00 ± 1.77
334.00 ± 10.93 a* 9.58
303.00 ± 3.90 b* 17.95

Table 1 values the mean ± S.E of 5 samples per group (ms – millisecond; bpm – beats per minute). The percentage changes in
each ECG parameters are indicated by red (increase) and blue (decrease) arrows. Group comparison: a – NOR vs. NAC; b –
NOR vs. ISO. Statistical significance (p < 0.05) indicated by *.

Table 2. Hypertrophic indices among experimental rats.
Groups
I - NOR

Body weight
(BW in g)
110.36 ± 3.65

Heart weight
(HW in g)
0.320 ± 0.010

HW/BW ratio
2.92 ± 0.12

II - NAC 40.00 ± 3.65 a*

0.363 ± 0.005 a* 9.05 ± 0.95 a*

III - ISO

0.750 ± 19.58 b* 8.41 ± 0.71 b*

90.00 ± 7.30 b*

Table 2 shows the mean ± S.E of 5 samples per group. Group
comparison: a – NOR vs. NAC; b – NOR vs. ISO. Statistical
significance (p < 0.05) indicated by*.

high in NAC that also indicated only trace levels of
3-hydroxybutyrate. Similarly, mannonic acid, ribose and
erythrose were observed intensely in ISO group whereas
galactose and mannose were found at trace levels (Table
3).
3.5. Correlation analysis
Pearson’s correlation analysis revealed the most strongly
correlating metabolites between other metabolites and with
the seven metabolic responders (3-hydroxybutyrate, lactic
acid, urea, QRS complex, R-amplitude, R-R interval, heart
rate) (Figure 1). Alanine was the least strong metabolite in
the NAC model and no metabolites correlated with QRS
complex in the ISO model. Isoleucine, fructose, galactose,
and cholesterol correlated directly and strongly with
heart rate in the NAC model, besides 3-hydroxybutyrate,
QRS complex and R-amplitude. Galactose, mannose,
and cholesterol correlated negatively and significantly
with other metabolites in the ISO model (Figure S4).
Correlation analysis accompanied by pattern hunting
revealed the correlates for seven metabolic responders
(Figure S5 and Figure S6).
3.6. Multiple regression analysis
No significant predictors for R-amplitude in the NAC
model and for QRS complex in the ISO model were
depicted. Succinic acid and proline were the significant
predictors commonly distributed in both CH models. The
order of strong fit models with higher and significant R2

values were fructose > valine > proline > succinic acid >
butanoic acid in NAC and proline > cholesterol > succinic
acid > erythrose > isoleucine in the ISO model (Table 4
and Table 5).
3.7. Pathway mapping in the models
Arginine and proline metabolism along with branched
chain amino acid degradation were mapped as highly
influenced common pathways in both the NAC and ISO
models by MSEA. Butyrate metabolism was identified as
the most significant pathway in the NAC model (p < 0.05).
Moreover, analysis revealed the panel of other significantly
influenced metabolic pathways but with less significance
(Figure 2 and Figure S7).
4. Discussion
The primary indicator of CH are the typical
electrocardiographic features such as widened QRS
complex and prolonged R-R interval with delayed heart
rate which were displayed in the ISO model of this study.
On the other hand, the NAC model displayed unique
characteristics such as shortened R-amplitude and
prolonged R-R interval (Figure S1 and Table 1). Such
a pattern has been previously reported linked to dilated
cardiomyopathy, a condition that is closely associated with
CH (Finocchiaro et al., 2020). This was further justified
in this study by the elevated heart weight to body weight
ratio in the NAC model when compared to the ISO and
normal groups (Table 2 and Figure S2). Such an elevation
in the heart weight to body weight ratio was attributed to
extensive fibrosis (Wang et al., 2019).
Histopathological analysis revealed substantially
impaired cardiac architecture in NAC and ISO models
when compared to the normal model. Although NAC
had been previously reported as a potent antioxidant,
few alternative studies report on the contrary (Liu et al.,
2015). Thereby, NAC may trigger disease progression
probably through induction of reductive stress through
glutathione dependent mechanisms (Zhang et al., 2012).
In this study, administration of NAC for 2 weeks could
have induced accumulation of collagens and extracellular
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Table 3. Concentration of serum metabolites and unique fingerprint metabolites in
experimental groups identified using GC-MS analysis.
Normal (NOR)

N-acetyl-L-cysteine Isoproterenol
(NAC)
(ISO)

Leucine

1.60 ± 0.03
2.51 ± 0.20

9.86 ± 0.22 a*
12.82 ± 0.21 a*

3.65 ± 0.15b
7.19 ± 0.11 b

Isoleucine

0.96 ± 0.09

0.03 ± 0.001 a*

4.08 ± 0.13 b

Serine

0.39 ± 0.05

17.89 ± 0.18 a*

7.81 ± 0.21 b*

Threonine

0.21 ± 0.14

19.26 ± 0.25

9.27 ± 0.15 b*

Alanine

1.45 ± 0.26

1.91 ± 0.19 a

Glutamic acid

0.03 ± 0.001

19.32 ± 0.22

Glycine

0.12 ± 0.03

3.55 ± 0.15 a

8.43 ± 0.23 b*

Proline

1.08 ± 0.11

2.80 ± 0.10

3.40 ± 0.13 b*

Norleucine

0.01 ± 0.002

0.015 ± 0.0001 a*

1.38 ± 0.16 b*

Sugars Xylitol

1.48 ± 0.17

100.68 ± 0.02

82.42 ± 0.16 b*

Fructose

1.29 ± 0.08

0.01 ± 0.002 a*

20.64 ± 0.23 b*

Galactose

13.84 ± 0.02

1.40 ± 0.08

0.08 ± 0.001 b*

Ribose

0.07 ± 0.003

0.01 ± 0.002 a*

47.19 ± 0.15 b*

Glucose

12.80 ± 0.08

182.72 ± 0.29

160.50 ± 0.23 b*

Mannose

0.19 ± 0.007

8.31 ± 0.14 a*

Inositol

3.30 ± 0.04

21.17 ± 0.14 a*

Erythrose

0.09 ± 0.001

0.016 ± 0.0005

Mannonic acid

0.04 ± 0.003

0.01 ± 0.001 a*

1.93 ± 0.12 b*

2-deoxy-D-galactopyranose 0.06 ± 0.002

3.52 ± 0.26

3.51 ± 0.18 b*

Succinic acid

0.01 ± 0.002

3.78 ± 0.29 a

Lipids Propanoic acid

0.66 ± 0.05

114.33 ± 0.61

Butanoic acid

0.06 ± 0.004

3.06 ± 0.23 a*

0.01 ± 0.001 b*

Palmitic acid

4.22 ± 0.05

29.93 ± 0.20

39.68 ± 0.21 b*

Oleic acid

0.27 ± 0.01

7.27 ± 0.18 a

Cholesterol

Metabolites (mmol mL–1)
Amino acids Valine

a*

5.06 ± 0.13 b*
11.40 ± 0.11 b*

a*

a*

a*

a

a*

0.03 ± 0.003 b*
22.78 ± 0.17 b*
a*

a*

1.54 ± 0.19 b*

2.23 ± 0.16 b
a*

a*

305.57 ± 0.24 b

19.25 ± 0.27 b*

1.63 ± 0.04

0.01 ± 0.004

a*

0.09 ± 0.003 b*

3-Hydroxybutyrate

3.60 ± 0.02

0.01 ± 0.002 a*

29.05 ± 0.26 b*

Lactic acid

12.85 ± 0.21

127.07 ± 0.27 a*

112.51 ± 0.25 b*

Urea

11.02 ± 0.07

379.44 ± 1.11

97.57 ± 0.17 b

a*

Table values defined as the mean ± S.E of 5 samples per group. Group comparison a Normal (group I) vs. NAC (group II); b - normal (group I) vs. ISO (group III). Statistical
significance (p < 0.05) indicated *. Blue shows metabolites uniquely present only in
both NAC and ISO; red shows metabolites found as trace in both NAC and ISO but
present only in NOR; green shows metabolites uniquely present in NAC; orange shows
metabolites at trace levels only in NAC; purple shows metabolites uniquely present in
ISO and pink shows metabolites at trace levels only in ISO.

matrix proteins which have led to cardiac fibrosis. These
changes were indicated by the decrease in R-amplitude,
reduction in body weight (cachexia), and increase in
hypertrophy index due to shift in metabolism towards
energy sustenance (Edwards, 1974; Larssen et al., 2017).
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Though previously NAC was reported contrarily towards
intervening cachexia in HIV patients, the same study
indicated for a precaution about dosages (Droge et al.,1997;
Delafontaine and Akao, 2006) as established in this study
primarily through ECG and HW/BW ratio. This hereby
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Figure 1. Correlation heat map for NAC induced CH. Pearson’s correlation analysis revealed strong correlation (scores
≥ 0.7) between most of the metabolites and with the seven metabolic responders in most of the serum metabolites in
NAC model, in which alanine was observed as the least strong.

warrants focussed pathophysiological understanding in
terms of dilation and cachexia underlying the NAC and
reductive stress in CH.
The respective list of predictors identified in NAC
(reductive stress) and ISO (oxidative stress) models of CH
in this study mapped branched chain amino acid (BCAA)
degradation pathway as one of the mechanistic routes
underlying pathological remodelling. Previous studies
indicated the two possible sides of impaired branched
chain amino acid catabolism: (i) increased leucine,
valine, and isoleucine in CH due to low expression of
catabolic enzymes and that excessive circulating leucine
can influence metabolic homeostasis that can induce
systolic dysfunction (Gibb and Hill, 2017) (ii) elevated
plasma leucine can decrease the plasma levels of valine
and isoleucine by affecting branched-chain ketoacid
dehydrogenase (Tom and Nair, 2006). This study displays
both of these phenomena as leucine levels were increased
in both CH models, valine and isoleucine levels were
decreased in the NAC model but they were raised in
the ISO model (Table 3). The catabolites of isoleucine
are ketogenic compounds namely acetoacetate, acetyl

coenzyme and the glucogenic counterpart, succinyl
coenzyme A (Tom and Nair, 2006). These elements of the
ketone body metabolism could be the reason for isoleucine
to be identified as a predictor of 3-hydroxybutyrate(3-HB)
in the ISO model. Similarly, valine was identified as a
predictor of urea in the NAC model of this study. Previous
studies reported elevated valine levels as a biomarker of
diabetic cardiomyopathy. In renal disorder associated with
CH, urea production was associated with the amino acid
catabolism that was influenced by valine levels (Veeneman
et al., 2004; Liao et al., 2019).
This study highlights proline as a crucial metabolite
in CH. Proline is a scavenger of free radicals which
are associated with glutathione biosynthesis, and this
amino acid is exogenously used to overcome ventricular
remodelling during oxidative stress (Wang et al., 2020).
Contrarily, this study displayed elevated proline levels at
the initial stages of CH in both the NAC and ISO models
(Table 3) which could be due to hyperprolinemia type I
(Wang et al., 2020) besides the participation of this elevated
proline in collagen formation and fibrosis. Proline was
also identified as a predictor for QRS complex in the NAC
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Table 4. Predictors for metabolic responders in NAC induced CH models.

QRS complex

Potent predictor
Prediction equation
metabolite
Proline
y = 23.596 + 0.971x

Predictor - linear model
fitness and its significance
R2 = 1.00; p = 0.001*

R-amplitude

Valine

y = –0.159 + 0.113x

R2 = 0.54; p = 0.067NS

R-R interval

Butanoic acid

y = 185.418 + 15.537x

R2 = 0.77; p = 0.002*

Heart rate/pulse rate (HR) Succinic acid

y = 310.825 + 28.664x

R2 = 0.97; p = 0.003*

3-HB

Fructose

y = 2.422 + 1.348x

R2 = 1.00; p = 8.2003E-7*

LA

Fructose

y = 134.113 + 9.851x

R2 =1.00; p = 0.00001*

Urea

Valine

y = 134.113 + 9.851x

R2 =1.00; p = 4.5625E-8*

Metabolic responders

Table 4 indicates the panel of metabolites (independent variable) that are potent predictor and their
respective responder (dependent variable) for NAC induced CH model along with their model
fitness wherein statistical significance (p < 0.05) indicated by * and nonsignificant as NS.

Table 5. Predictors for metabolic responders in ISO induced CH models.

QRS complex

Potent predictor
Prediction equation
metabolite
-----

Predictor - linear model
fitness and its significance
---

R-amplitude

Erythrose

y = –0.310 + 0.407x

R2 = 0.95; p = 0.009*

R-R interval

Succinic acid

y = 225.208 + 15.339x R2 = 0.97; p = 0.0002*

Metabolic responders

Heart rate/pulse rate (HR) Cholesterol

y = 226.292 + 80.412x R2 = 0.98; p = 0.001*

3-HB

Isoleucine

y = 32.334 + 0.598x

R2 = 0.73; p = 0.000007*

LA

Proline

y = 137.183 + 1.566x

R2 = 0.99; p = 1.9931E-8*

Urea

Proline

y = 103.677 + 2.956x

R2 = 1.00; p = 3.6906E-8*

Table 5 indicates the panel of metabolites (independent variable) that are potent predictor and their
respective responder (dependent variable) for ISO induced CH model along with their model fitness
and statistical significance (p < 0.05) indicated by *.

model besides its action upon lactic acid and urea in the
ISO model (Table 4) which were substantially supported
by the metabolite set enrichment analysis (Figure 2 and
Figure S7). Previous studies indicated arginine as the
source for proline and urea production since proline can
decrease lactate dehydrogenase that produces lactate in
the pathogenesis of CH (Revis and Cameron, 1978; Zheng
et al., 2018; Wang et al.,2020). These could be the rationale
for proline being identified as a predictor in the NAC and
ISO models.
In Figure 3, purple highlights are associated with the
NAC model and brown highlights indicate the ISO model
(diagram created using BioRender1). Proline and succinic
acid are common predictors identified in both CH models
similar to the common BCAA and arginine-proline
metabolisms. In this study, succinate was significantly
BioRender.com [accessed on 06.06.2021]

1
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elevated in both CH models when compared to the
normal model. Previous researches have observed similar
elevation in succinate levels during ischemia which may
cause arrhythmias (Aguiar et al., 2014; Tretter et al., 2016).
This might be the underlying mechanism for the reduction
in R-R intervals and heart rates of the NAC and ISO
models (Figure S1 and Table S1). This study hypothesizes
that succinic acid may become a putative biomarker for
CH and related dysrhythmia as it has been previously
reported in association with ROS homeostasis besides its
contribution towards energy metabolism.
Previous studies reported about the reduced expression
of biomarkers for CH in specific rat models through
inhibition of histone deacetylases by sodium butyrate
(Subramanian et al., 2016) wherein the beneficial effects
of butyrate on cellular growth were also specified (Lui et
al., 2018). In this study, butyrate metabolism was mapped
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Figure 2. Representation of highly influenced pathways mapped using MSEA. Butyrate metabolism mapped as highly
impacted pathway in NAC model followed by arginine and proline metabolism along with BCAA degradation that
were also found to be common in ISO (see Figure S7).

as a pathway that can be impacted highly by the predictors
of NAC (Figure 2). Butyric acid was significantly elevated
in the NAC model and significantly lowered in the ISO
model when compared to the normal model (Table 3).
This finding shows both effects of butyrate related with the
cellular stress mechanisms in the NAC and ISO models.
Another observation in this study was the low levels
of fructose in the NAC model and elevated levels of

fructose in the ISO model (Table 3). Previous studies
reported that high levels of fructose are associated with
oxidative stress, increased lactic acid production, and
decreased ketone body production in the ISO model. The
NAC model displaying very low levels of fructose could
be due to aberrant fructose metabolism as a concomitant
event of hypoxia inducible factor that is involved in
the pathogenesis of various diseases including CH

329

KUBERAPANDIAN and DOSS / Turk J Biol

Figure 3. Schematic representation of predictors and remodelling that impact the seven metabolic responders of CH in NAC and ISO
models. The figure represents the possible metabolic remodelling events in terms of pathways and metabolites that can be predictors/
biomarkers underlying the well-known mechanisms of redox stress in CH.

(Mirtschink et al., 2015). Thus, this study demonstrates the
role of fructose metabolism which varies in NAC and ISO
models. Fructose was identified as a predictor of lactic acid
and 3-hydroxybutyrate (3-HB) in the NAC model (Table
4) which suggested that fructose levels could correlate with
3-hydroxy butyrate and lactic acid directly. This finding
might explain the predictor relationship of fructose with
its responders, 3-hydroxybutyrate and lactic acid in the
NAC model (Rawat and Menahan, 1975; Yan 2014).
Cholesterol levels in both CH models were
significantly decreased (Table 4) which is in contrast to
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the well-established fact that hypercholesterolemia is
associated with CH by affecting membrane cholesterol
and impairing membrane receptors and ionic channels/
pumps, inducing oxidative stress via NADP(H) oxidase.
Hypocholesterolemia (low cholesterol) has been addressed
as a cellular response for pathophysiological mechanisms
of CH such as inflammation and in chronic heart failure
(Horwich et al., 2002; Rauchhaus et al., 2003). These
apparent mechanisms linked to arrhythmias hereby
justifies the relationship of cholesterol with heart rate as
the predictor and responder in the ISO model (Liao, 2004;

KUBERAPANDIAN and DOSS / Turk J Biol
Goonasekara et al., 2010) and thus warranting focus on
hypocholesterolemia in CH besides hypercholesterolemia.
This study indicates the elevation in erythrose level
in the ISO model and its identification as a predictor
of R-amplitude. There is scarce data about the role of
erythrose in energy metabolism and synthesis of aromatic
amino acids such as phenylalanine and tryptophan during
the pathogenesis of CH (Caggiano et al., 2020).
The present study emphasizes the identification and
relationship of eight significant metabolites as potent
predictors for the seven routinely diagnosed clinical
responders of CH comorbidities along with the three highly
influenced pathways as initial metabolic remodelling
events that eventually evolve into the advanced stage
cardiac hypertrophy and cardiac failure. Their application
can be a screening tool for the onset of CH which would
allow clinical intervention as early as possible. Thus, this
study highlights the clinical implication of NAC that
can be used to develop an animal model of CH and this
model would help in future studies to overcome current
limitations, especially in investigating the expression of

Nrf2 along with the levels of glutathione which would
indicate reductive stress.
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Supplementary material

Figure S1. Graphical representation of CH using ECG (scaled to the real time raw ECG tracings). Typical CH characteristics namely
widened QRS complex, elevated R-amplitude with prolonged R-R interval indicating delayed HR were observed in the standard
model, ISO. Interestingly, NAC displayed widened QRS complex with impaired R-R interval and HR but with contrarily shortened R
amplitude suggestive of the adverse fibrosis and an extended stage of CH, the dilated cardiomyopathy.

Figure S2. Morphological differences in heart sizes. When compared normal, the NAC and ISO administered rats revealed enlarged
heart sizes in particular, the ventricles along with impaired arterial structures as shown in the figure that is scaled to graph.

1

KUBERAPANDIAN and DOSS / Turk J Biol

Figure S3. H&E staining of ventricles. (i) Left ventricle (LV): NAC (Figure b) and ISO (Figure c) displayed hypertrophied nuclei (HN)
with distorted muscle fibers (DMF) and loss of connective tissue separations (CTS) when compared to normal (Figure a). (ii) Right
ventricle (RV): similar patterns identified in LV were also observed in RV (Figures d to f). NAC revealed extensive thickened myofibrils
(TMF) than ISO when compared to normal.
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Figure S4. Correlation heat map for ISO induced CH. Unlike NAC, the ISO model revealed no strong correlating metabolites for QRS
complex accompanied by metabolites that strongly correlated between themselves and other six metabolic responders among which
mannose was found as least.
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Figure S5a. Pattern hunting analysis to identify metabolites that
correlate with QRS complex in NAC administered rat group.
Metabolites that strongly correlate (coefficients > 0.7; positively
correlated – pink; negatively correlated – blue) with the metabolite
responder QRS complex are indicated.

Figure S5b. Pattern hunting analysis to identify metabolites that correlate with R-amplitude in NAC administered rat group. Metabolites
that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite responder
R-amplitude are indicated.
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Figure S5c. Pattern hunting analysis to identify metabolites that correlate with
R-R interval in NAC administered rat group. Metabolites that strongly correlate
(coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with
the metabolite responder R-R interval are indicated.

Figure S5d. Pattern hunting analysis to identify metabolites that correlate with heart rate in NAC administered rat group. Metabolites
that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite responder heart
rate are indicated.
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Figure S5e. Pattern hunting analysis to identify metabolites that
correlate with the ketone body, 3-hydroxybutyrate (3-HB) in
NAC administered rat group. Metabolites that strongly correlate
(coefficients > 0.7; positively correlated – pink; negatively correlated
– blue) with the metabolite responder 3-HB are indicated.

Figure S5f. Pattern hunting analysis to identify metabolites that correlate with lactic acid (LA) in NAC administered rat group.
Metabolites that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite
responder LA are indicated.
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Figure S5g. Pattern hunting analysis to identify metabolites that
correlate with urea in NAC administered rat group. Metabolites that
strongly correlate (coefficients > 0.7; positively correlated – pink;
negatively correlated – blue) with the metabolite responder urea are
indicated.

Figure S6a. Pattern hunting analysis to identify metabolites that correlate with QRS complex in ISO administered rat group. Metabolites
that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite responder QRS
complex are indicated.
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Figure S6b. Pattern hunting analysis to identify metabolites that
correlate with R-amplitude in ISO administered rat group. Metabolites
that strongly correlate (coefficients > 0.7; positively correlated – pink;
negatively correlated – blue) with the metabolite responder R-amplitude
are indicated.

Figure S6c. Pattern hunting analysis to identify metabolites that correlate with R-R interval in ISO administered rat group. Metabolites
that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite responder R-R
amplitude are indicated.
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Figure S6d. Pattern hunting analysis to identify metabolites that
correlate with heart rate (HR) in ISO administered rat group.
Metabolites that strongly correlate (coefficients > 0.7; positively
correlated – pink; negatively correlated – blue) with the metabolite
responder HR are indicated.

Figure S6e. Pattern hunting analysis to identify metabolites that correlate with ketone body, 3-hydroxybuytrate (3-HB) in ISO
administered rat group. Metabolites that strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue)
with the metabolite responder 3-HB are indicated.
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Figure S6f. Pattern hunting analysis to identify metabolites that correlate
with ketone body, 3-hydroxybuytrate (3-HB) in ISO administered rat
group. Metabolites that strongly correlate (coefficients > 0.7; positively
correlated – pink; negatively correlated – blue) with the metabolite
responder 3-HB are indicated.

Figure S6g. Pattern hunting analysis to identify metabolites that correlate with urea in ISO administered rat group. Metabolites that
strongly correlate (coefficients > 0.7; positively correlated – pink; negatively correlated – blue) with the metabolite responder urea are
indicated.
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Figure S7. Pathway mapping by MSEA in ISO model. Arginine and proline metabolism along with BCAA
degradation are commonly shown as significantly influenced in both CH models (p < 0.05). Though there
are other highly impacted metabolic pathways listed in the figure, their level of significance, p > 0.05.
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